doi: 10.3389/fphar.2025.1587314 Received 04 March 2025 Accepted 21 April 2025 Published 28 April 2025 Volume 16 - 2025 Edited by Ramzi Mothana, King Saud University, Saudi Arabia Reviewed by Jovana Rajkovic, University of Belgrade, Serbia Sidharth Mehan, Indo-Soviet Friendship College of Pharmacy, India Updates Copyright 2025 Jiang, Lhamo, Ma, Ye, Chen, He, Xu and Huang
A consensus report by ADA and EASD
Semaglutide (marketed under brand names like Wegovy and Ozempic) and Tirzepatide (Mounjaro and Zepbound) are GLP-1 receptor agonists that help regulate appetite, insulin, and metabolism
Quick Energy Boost You Can Feel Same Day: Many patients notice improved energy, focus, and mood within hours of a B12 or B-complex injection
Lactobacillus reuteri DSM 17938 in infantile colic: a randomized, double-blind, placebo-controlled trial